ASSURANT, INC.
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
19. Equity Transactions
- Equity Transactions
Common Stock
Changes in the number of shares of common stock outstanding are as follows for the periods presented:
| December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Shares of common stock outstanding, beginning | 50,833,749 | 51,955,994 | 52,830,381 |
| Vested restricted stock and restricted stock units, net (1) | 163,265 | 178,120 | 170,911 |
| Issuance related to performance share units (1) | 131,078 | 133,136 | 142,091 |
| Issuance related to ESPP | 97,129 | 115,019 | 131,815 |
| Shares of common stock repurchased | (1,432,302) | (1,548,520) | (1,319,204) |
| Shares of common stock outstanding, ending | 49,792,919 | 50,833,749 | 51,955,994 |
(1)Vested restricted stock, restricted stock units and performance share units are shown net of shares of common stock retired to cover participant income tax liabilities.
The Company is authorized to issue 800,000,000 shares of common stock. In addition,150,001 shares of Class B common stock and 400,001 shares of Class C common stock are authorized but have not been issued.
Preferred Stock
The Company is authorized to issue 200,000,000 shares of preferred stock. As of December 31, 2025, none are outstanding.
Stock Repurchase
In November 2025, the Company’s Board of Directors (the “Board”) authorized the Company to repurchase up to $700.0 million aggregate cost at purchase of its outstanding common stock. In November 2023, the Board authorized the Company to repurchase up to $600.0 million aggregate cost at purchase of its outstanding common stock.
During the year ended December 31, 2025, the Company repurchased 1,432,302 shares of the Company’s outstanding common stock at a cost of $299.9 million, exclusive of commissions, leaving $774.6 million remaining in the aggregate under the November 2025 and November 2023 repurchase authorizations at December 31, 2025. During the years ended December 31, 2024 and 2023, the Company repurchased 1,548,520 and 1,319,204 shares of the Company’s outstanding common stock at a cost, exclusive of commissions, of $299.9 million and $200.0 million, respectively.
The timing and the amount of future repurchases will depend on market conditions, the Company’s financial condition, results of operations and liquidity and other factors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.